212 related articles for article (PubMed ID: 1348890)
1. Immunohistochemical studies on oncogene products (EGF-R, c-erbB-2) and growth factors (EGF, TGF-alpha) in human breast cancer: their relationship to oestrogen receptor status, histological grade, mitotic index and nodal status.
Umekita Y; Enokizono N; Sagara Y; Kuriwaki K; Takasaki T; Yoshida A; Yoshida H
Virchows Arch A Pathol Anat Histopathol; 1992; 420(4):345-51. PubMed ID: 1348890
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of TGF-alpha, EGF-R, c-erbB-2, c-H-ras, c-myc, estrogen and progesterone in benign and malignant human breast lesions: a concomitant expression.
Spaventi R; Kamenjicki E; Pecina N; Grazio S; Grazio S; Pavelic J; Kusic B; Cvrtila D; Danilovic Z; Spaventi S
In Vivo; 1994; 8(2):183-9. PubMed ID: 7919121
[TBL] [Abstract][Full Text] [Related]
3. Interaction of transforming growth factor-alpha and epidermal growth factor receptor in breast carcinoma. An immunohistologic study.
Castellani R; Visscher DW; Wykes S; Sarkar FH; Crissman JD
Cancer; 1994 Jan; 73(2):344-9. PubMed ID: 8293398
[TBL] [Abstract][Full Text] [Related]
4. Co-expression of epidermal growth factor receptor and transforming growth factor-alpha predicts worse prognosis in breast-cancer patients.
Umekita Y; Ohi Y; Sagara Y; Yoshida H
Int J Cancer; 2000 Nov; 89(6):484-7. PubMed ID: 11102891
[TBL] [Abstract][Full Text] [Related]
5. Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium.
Niikura H; Sasano H; Kaga K; Sato S; Yajima A
Hum Pathol; 1996 Mar; 27(3):282-9. PubMed ID: 8600044
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical demonstration of growth factors, TGF-alpha, TGF-beta, IGF-I and neu oncogene product in benign and malignant human breast tissues.
Mizukami Y; Nonomura A; Yamada T; Kurumaya H; Hayashi M; Koyasaki N; Taniya T; Noguchi M; Nakamura S; Matsubara F
Anticancer Res; 1990; 10(5A):1115-26. PubMed ID: 1978632
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical studies on oncogene products (c-erbB-2, EGFR, c-myc) and estrogen receptor in benign and malignant breast lesions. With special reference to their prognostic significance in carcinoma.
Tauchi K; Hori S; Itoh H; Osamura RY; Tokuda Y; Tajima T
Virchows Arch A Pathol Anat Histopathol; 1989; 416(1):65-73. PubMed ID: 2573192
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor, transforming growth factor-alpha, and epidermal growth factor receptor localization in the baboon (Papio anubis) uterus during the menstrual cycle and early pregnancy.
Slowey MJ; Verhage HG; Fazleabas AT
J Soc Gynecol Investig; 1994; 1(4):277-84. PubMed ID: 9419784
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of epidermal growth factor receptor (EGF-R) and c-neu/erbB2 expression in glioblastomas (GBMs).
Hiesiger EM; Hayes RL; Pierz DM; Budzilovich GN
J Neurooncol; 1993 May; 16(2):93-104. PubMed ID: 7507162
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor, transforming growth factor-alpha, and epidermal growth factor receptor localization in the baboon (Papio anubis) oviduct during steroid treatment and the menstrual cycle.
Schell DL; Mavrogianis PA; Fazleabas AT; Verhage HG
J Soc Gynecol Investig; 1994; 1(4):269-76. PubMed ID: 9419783
[TBL] [Abstract][Full Text] [Related]
11. p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor.
Poller DN; Hutchings CE; Galea M; Bell JA; Nicholson RA; Elston CW; Blamey RW; Ellis IO
Br J Cancer; 1992 Sep; 66(3):583-8. PubMed ID: 1355662
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of a TGF-alpha-EGF-receptor autocrine loop and c-myc protein over-expression in papillary thyroid carcinomas.
Haugen DR; Akslen LA; Varhaug JE; Lillehaug JR
Int J Cancer; 1993 Aug; 55(1):37-43. PubMed ID: 8102129
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapy.
Nicholson RI; McClelland RA; Gee JM; Manning DL; Cannon P; Robertson JF; Ellis IO; Blamey RW
Breast Cancer Res Treat; 1994 Jan; 29(1):117-25. PubMed ID: 7912565
[TBL] [Abstract][Full Text] [Related]
14. The epidermal growth factor family in pulmonary carcinoids: immunohistochemical evidence of growth-promoting circuits.
Battista P; Pizzicannella G; Vitullo P; Palmirotta R; Mariani-Costantini R
Mod Pathol; 1993 Mar; 6(2):162-6. PubMed ID: 8097879
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical localization of cathepsin D, proliferating cell nuclear antigen and epidermal growth factor receptor in human breast carcinoma analysed by computer image analyser: correlation with histological grade and metastatic behaviour.
Okamura K; Kobayashi I; Matsuo K; Kiyoshima T; Yamamoto K; Miyoshi A; Sakai H
Histopathology; 1997 Dec; 31(6):540-8. PubMed ID: 9447385
[TBL] [Abstract][Full Text] [Related]
16. Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features.
Gasparini G; Gullick WJ; Bevilacqua P; Sainsbury JR; Meli S; Boracchi P; Testolin A; La Malfa G; Pozza F
J Clin Oncol; 1992 May; 10(5):686-95. PubMed ID: 1349034
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patients.
Osaki A; Toi M; Yamada H; Kawami H; Kuroi K; Toge T
Am J Surg; 1992 Oct; 164(4):323-6. PubMed ID: 1357997
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic value of epidermal growth factor receptor, transforming growth factor-alpha, and c-erb B-2 in nephroblastoma.
Ghanem MA; Van Der Kwast TH; Den Hollander JC; Sudaryo MK; Mathoera RB; Van den Heuvel MM; Noordzij MA; Nijman RJ; van Steenbrugge GJ
Cancer; 2001 Dec; 92(12):3120-9. PubMed ID: 11753991
[TBL] [Abstract][Full Text] [Related]
19. Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer.
Wright C; Nicholson S; Angus B; Sainsbury JR; Farndon J; Cairns J; Harris AL; Horne CH
Br J Cancer; 1992 Jan; 65(1):118-21. PubMed ID: 1346366
[TBL] [Abstract][Full Text] [Related]
20. EGF-R and steroid receptors in breast cancer: a comparison with tumor grading, tumor size, lymph node involvement, and age.
Zeillinger R; Kury F; Speiser P; Sliutz G; Czerwenka K; Kubista E
Clin Biochem; 1993 Jun; 26(3):221-7. PubMed ID: 8392451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
